Efficacy of Trabectedin in Patients with Advanced Translocation‐Related Sarcomas: Pooled Analysis of Two Phase II Studies

BACKGROUND. Trabectedin is reported as effective, especially against translocation‐related sarcomas (TRSs) after failure of or intolerance to standard chemotherapy. We conducted two phase II studies of TRS, confirming high efficacy of 1.2 mg/m(2) trabectedin. The updated data of 66 patients in these...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Mitsuru, Takahashi, Shunji, Araki, Nobuhito, Sugiura, Hideshi, Ueda, Takafumi, Yonemoto, Tsukasa, Morioka, Hideo, Hiraga, Hiroaki, Hiruma, Toru, Kunisada, Toshiyuki, Matsumine, Akihiko, Shimura, Masashi, Kawai, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Sarcomas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553952/
https://www.ncbi.nlm.nih.gov/pubmed/28526720
http://dx.doi.org/10.1634/theoncologist.2016-0064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553952/
https://www.ncbi.nlm.nih.gov/pubmed/28526720
http://dx.doi.org/10.1634/theoncologist.2016-0064

Ejemplares similares